Cardiovasc Drugs Ther
From Bioblast
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Journal title and website | Cardiovascular Drugs and Therapy |
---|
Publications
Reference | Published | View | |
---|---|---|---|
Alexander 2022 Cardiovasc Drugs Ther | Alexander ED, Aldridge JL, Burleson TS, Frasier CR (2022) Teriflunomide treatment exacerbates cardiac ischemia reperfusion injury in isolated rat hearts. https://doi.org/10.1007/s10557-022-07341-z | 2022 | Cardiovasc Drugs Ther 37:1021-26. PMID: 35488973 Open Access |
Makrecka-Kuka 2020 Cardiovasc Drugs Ther | Makrecka-Kuka Marina, Korzh Stanislava, Videja Melita, Vilks Karlis, Cirule Helena, Kuka Janis, Dambrova Maija, Liepinsh Edgars (2020) Empagliflozin protects cardiac mitochondrial fatty acid metabolism in a mouse model of diet-induced lipid overload. Cardiovasc Drugs Ther 34:791-97. | 2020 | PMID: 32424653 |
Larsen 2020 Cardiovasc Drugs Ther | Larsen AH, Wiggers H, Dollerup OL, Jespersen NR, Hansson NH, Frøkiær J, Brøsen K, Nørrelund H, Bøtker HE, Møller N, Jessen N (2020) Metformin lowers body weight but fails to increase insulin sensitivity in chronic heart failure patients without diabetes: a randomized, double-blind, placebo-controlled study. Cardiovasc Drugs Ther 35:491-503. | 2020 | PMID: 32770520 |